KC, Govinda B. http://orcid.org/0000-0003-0417-3120
Bocci, Giovanni http://orcid.org/0000-0002-9361-8437
Verma, Srijan
Hassan, Md Mahmudulla http://orcid.org/0000-0003-4782-3736
Holmes, Jayme
Yang, Jeremy J.
Sirimulla, Suman http://orcid.org/0000-0003-4665-6665
Oprea, Tudor I. http://orcid.org/0000-0002-6195-6976
Funding for this research was provided by:
National Science Foundation (DMR-1827745)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (U24 CA224370)
Article History
Received: 12 September 2020
Accepted: 17 March 2021
First Online: 3 May 2021
Competing interests
: T.I.O. has received honoraria from or consulted for Abbott, AstraZeneca, Chiron, Genentech, Infinity Pharmaceuticals, Merz Pharmaceuticals, Merck Darmstadt, Mitsubishi Tanabe, Novartis, Ono Pharmaceuticals, Pfizer, Roche, Sanofi and Wyeth, and is on the Scientific Advisory Board of ChemDiv and InSilico Medicine.
Free to read: This content has been made available to all.